Literature DB >> 14632649

Human T-cell responses to the RD1-encoded protein TB27.4 (Rv3878) from Mycobacterium tuberculosis.

Else Marie Agger1, Inger Brock, Limei Meng Okkels, Sandra M Arend, Claus S Aagaard, Karin N Weldingh, Peter Andersen.   

Abstract

In recent years, there has been considerable focus on the discovery and characterization of proteins derived from Mycobacterium tuberculosis leading to the identification of a number of candidate antigens for use in vaccine development or for diagnostic purposes. Previous experiments have demonstrated an important immunological role for proteins encoded by the RD1 region, which is absent from all strains of bacillus Calmette-Guérin (BCG) but present in the genomes of virulent M. bovis and M. tuberculosis. Herein, we have studied human T-cell responses to the antigen encoded by the putative open reading frame (rv3878) of the RD1 region. Immunoblot analysis revealed that rv3878 was expressed and the native protein was designated TB27.4. Immunological evaluations demonstrate that TB27.4 elicits a prominent immune response in human tuberculosis patients with a dominant region in the C-terminal part of the molecule. In contrast, very limited responses were seen in M. bovis BCG-vaccinated donors. This study therefore emphasizes the diagnostic potential of proteins encoded by the RD1 region.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14632649      PMCID: PMC1783067          DOI: 10.1111/j.1365-2567.2003.01763.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Identification of immunodominant antigens during infection with Mycobacterium tuberculosis.

Authors:  P Andersen; D Askgaard; A Gottschau; J Bennedsen; S Nagai; I Heron
Journal:  Scand J Immunol       Date:  1992-12       Impact factor: 3.487

2.  HLA class II restriction repertoire of antigen-specific T cells. II. Evidence for a new restriction determinant associated with DRw52 and LB-Q1.

Authors:  T H Ottenhoff; D G Elferink; A Termijtelen; F Koning; R R de Vries
Journal:  Hum Immunol       Date:  1985-06       Impact factor: 2.850

3.  Comparative genomics of BCG vaccines by whole-genome DNA microarray.

Authors:  M A Behr; M A Wilson; W P Gill; H Salamon; G K Schoolnik; S Rane; P M Small
Journal:  Science       Date:  1999-05-28       Impact factor: 47.728

4.  A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10).

Authors:  Fransois-Xavier Berthet; Peter Birk Rasmussen; Ida Rosenkrands; Peter Andersen; Brigitte Gicquel
Journal:  Microbiology (Reading)       Date:  1998-11       Impact factor: 2.777

5.  Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis.

Authors:  P Ravn; A Demissie; T Eguale; H Wondwosson; D Lein; H A Amoudy; A S Mustafa; A K Jensen; A Holm; I Rosenkrands; F Oftung; J Olobo; F von Reyn; P Andersen
Journal:  J Infect Dis       Date:  1999-03       Impact factor: 5.226

6.  Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis.

Authors:  Alexander S Pym; Priscille Brodin; Laleh Majlessi; Roland Brosch; Caroline Demangel; Ann Williams; Karen E Griffiths; Gilles Marchal; Claude Leclerc; Stewart T Cole
Journal:  Nat Med       Date:  2003-04-14       Impact factor: 53.440

7.  Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis.

Authors:  A L Sørensen; S Nagai; G Houen; P Andersen; A B Andersen
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

8.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

9.  Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis.

Authors:  G G Mahairas; P J Sabo; M J Hickey; D C Singh; C K Stover
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490

10.  Genomic approach to identification of Mycobacterium bovis diagnostic antigens in cattle.

Authors:  Claus Aagaard; Marc Govaerts; Limei Meng Okkels; Peter Andersen; John M Pollock
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

View more
  8 in total

1.  Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold in-tube assay.

Authors:  Victor Herrera; Ellen Yeh; Kelly Murphy; Julie Parsonnet; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

2.  Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection.

Authors:  Annemieke Geluk; Michèl R Klein; Kees L M C Franken; Krista E van Meijgaarden; Brigitte Wieles; Kelly Cristina Pereira; Samira Bührer-Sékula; Paul R Klatser; Patrick J Brennan; John S Spencer; Diana L Williams; Maria C V Pessolani; Elizabeth P Sampaio; Tom H M Ottenhoff
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Assessing the serodiagnostic potential of 35 Mycobacterium tuberculosis proteins and identification of four novel serological antigens.

Authors:  Karin Weldingh; Ida Rosenkrands; Limei Meng Okkels; T Mark Doherty; Peter Andersen
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

4.  Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection.

Authors:  Inger Brock; Karin Weldingh; Eliane M S Leyten; Sandra M Arend; Pernille Ravn; Peter Andersen
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

5.  Assessment of Mycobacterium tuberculosis OmpATb as a novel antigen for the diagnosis of bovine tuberculosis.

Authors:  Irene Schiller; H Martin Vordermeier; W Ray Waters; Mitchell Palmer; Tyler Thacker; Adam Whelan; Roland Hardegger; Beatrice Marg-Haufe; Alex Raeber; Bruno Oesch
Journal:  Clin Vaccine Immunol       Date:  2009-07-08

6.  Impairment of IFN-gamma response to synthetic peptides of Mycobacterium tuberculosis in a 7-day whole blood assay.

Authors:  Hannah Priyadarshini Gideon; Melissa Shea Hamilton; Kathryn Wood; Dominique Pepper; Tolu Oni; Ronnett Seldon; Claire Banwell; Paul R Langford; Robert J Wilkinson; Katalin A Wilkinson
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

Review 7.  Immunological Characterization of Proteins Expressed by Genes Located in Mycobacterium tuberculosis-Specific Genomic Regions Encoding the ESAT6-like Proteins.

Authors:  Abu Salim Mustafa
Journal:  Vaccines (Basel)       Date:  2021-01-07

8.  Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses.

Authors:  Anat Zvi; Naomi Ariel; John Fulkerson; Jerald C Sadoff; Avigdor Shafferman
Journal:  BMC Med Genomics       Date:  2008-05-28       Impact factor: 3.063

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.